
What I wish someone had told me about fundraising, governance, and the decisions that actually kill biotech companies.
From a fellow CEO who's raised £40M+, watched companies fail, and is still in the arena.
The conversations biotech CEOs need to have but rarely do
Most biotech content is written by journalists, consultants, or people who've never sat in your chair.
This is different. I'm currently raising a Series A at Santero Therapeutics.
I've built companies, served on boards, and watched governance failures destroy ventures with good science.
I write about what I've learned: the hard way.
No corporate speak. No recycled advice.
Just honest perspective from someone navigating the same challenges you are.
Explore recent posts on fundraising, leadership, and building biotech companies in the UK